BJ I hope you're right about that $100 share price.  Can you explain how the process works if Cellceutix decides to sell off each compound to separate companies?  My question is, will the investor get stock in each of those companies or just paid out.  And how will the shares we currently hold be transferred if that does happen?

I also believe that Leo has everything orchestrated behind the scenes at this point, with a plan to maximize share price.  He has done a great job and I see it continuing on through to sale of these compounds.  After speaking to many folks, most much older and very much more experienced in the market than I, there is a consensus amongst them all.  They all say, "I have never seen anything like this company before."  Potential for major dollars, but the fallback of multiple compounds to safeguard the investor.  Pretty good place to be if you've been lucky enough to get into the loop.